ClinicalTrials.Veeva

Menu

Effect of Music Therapy on Infants with Neonatal Abstinence Syndrome

Mount Sinai Health System logo

Mount Sinai Health System

Status

Enrolling

Conditions

NAS

Treatments

Other: Ocean disc
Other: Gato box
Behavioral: Song of Kin
Other: Tonal Vocal holding
Other: Muted shaker
Other: Contingent singing

Study type

Interventional

Funder types

Other

Identifiers

NCT03533985
GCO 16-1991
IRB 16-00740 (Other Identifier)

Details and patient eligibility

About

This study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.

Full description

The purpose of this exploratory pilot study is to learn what, if any, effects live music therapy interventions have on the pacification, stabilization, and development of infants diagnosed with Neonatal Abstinence Syndrome (NAS). Neonatal Abstinence Syndrome is a group of problems that occur in a newborn who has been exposed to illegal or prescription opiates while in the mother's womb. Participants will receive 6 music therapy sessions over a 14-day period based on a randomized treatment schedule of 6 different interventions.

Enrollment

200 estimated patients

Sex

All

Ages

28+ weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

Infants who meet the following inclusion criteria will be eligible to participate in the study irrespective of race, religion, ethnicity, or gender:

  • Admitted to the NICU immediately postpartum
  • Gestational age 28 weeks or older
  • No identified hearing disorder
  • Do not have a diagnosed developmental disability (i.e. Down Syndrome)
  • Do not have Fetal Alcohol Syndrome
  • Medically cleared to participate in the study by nurse or neonatologist
  • Parent or legal guardian able/willing to give consent & complete the PBQ (Postpartum Bonding Questionnaire)

Exclusion criteria

  • Admitted to the NICU at any time other than immediately postpartum
  • Gestational age <28 weeks old
  • Has an identified hearing disorder
  • Has diagnosed developmental disability (i.e. Down syndrome)
  • Has Fetal Alcohol Syndrome
  • Is not medically cleared to participate in the study by the nurse or neonatologist
  • Parent or legal guardian unable/unwilling to give consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

200 participants in 6 patient groups

Song of Kin
Experimental group
Description:
Voice (with or without guitar)- lullaby/ Holding meter
Treatment:
Behavioral: Song of Kin
Gato box
Experimental group
Description:
Simple rhythms using Remo Gato box will be played by the MT-BC using a 3rd to comfort, engage or sedate
Treatment:
Other: Gato box
Ocean disc
Experimental group
Description:
Creating a consistent womb-like sound soundscape to comfort, engage or sedate
Treatment:
Other: Ocean disc
Contingent singing
Experimental group
Description:
Provision of communicative vocalization-"parantese" to engage with infants, prosodic responses to infant cues (eye contact, body position)
Treatment:
Other: Contingent singing
Tonal Vocal holding
Experimental group
Description:
Providing a 'blanket of tone' to comfort, engage or sedate
Treatment:
Other: Tonal Vocal holding
Muted shaker
Experimental group
Description:
If infant is awake, the muted shaker will be used to entrain to the infant's vital signs-to comfort, soothe or sedate
Treatment:
Other: Muted shaker

Trial contacts and locations

6

Loading...

Central trial contact

Joanne Loewy, DA, LCAT, MT-BC; Elizabeth Barone, MA, MT-BC, CCLS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems